David Sarwer
@davidbsarwer
Followers
931
Following
21K
Media
62
Statuses
2K
Senior Associate Dean for Research and Strategic Initiatives, Director of Center for Obesity Research and Education, College of Public Health, Temple University
Blue Bell, PA
Joined April 2016
Thrilled to have my recent article in @ConversationUS featured along side those of @marionnestle and @astokespop in this great piece by @ConscienHealth on the importance of obesity prevention and treatment. @TempleCPH @TempleResearch @TempleUniv @WorldObesity @ObesitySociety
We agree when @marionnestle, @astokespop, and @davidbsarwer say don't neglect #ObesityPrevention. But we are suspecting that market dynamics are doing more to bend the curve than many health advocates. It's time to catch up with reality. https://t.co/POl7boJvPc
0
3
3
We publish four scientific journals featuring the most up to date and cutting-edge research in the field of #obesity. Free content from each journal is available to read each month. ➡️ Find out more here: https://t.co/ss0MBVcg1U
#FridayFindings
0
1
2
🚨 Treatment discontinuation is common in patients receiving semaglutide or tirzepatide for obesity. This is the first US study to quantify the specific reasons for discontinuation in clinical practice. https://t.co/Yy0W51bnPz
2
3
4
Reasons for Discontinuation of Obesity Pharmacotherapy With Semaglutide or Tirzepatide in Clinical Practice - Gasoyan - Obesity
onlinelibrary.wiley.com
Objective This study aimed to characterize the reasons for treatment discontinuation with injectable semaglutide or tirzepatide for obesity in regular clinical practice. Methods This cross-section...
0
5
10
Journal Watch: Our regular round-up includes laparoscopic reversal of gastric bypass, surgery vs GLP-1ras, GLP-1s in a plastic surgery setting, magnetic sphincter augmentation & post-LSG GERD, obesity severity and cancer screening, and more https://t.co/DwEsDg1ppv
0
1
1
Appreciate @BariatricNews picking up our recent article on utilization and potential misuse of GLP-1’s in the absence of training and experience in comprehensive obesity treatment. @TempleCPH @TempleResearch @TempleSBS @ConscienHealth @ObesityAction @prsjournal @WorldObesity
Researchers @TempleCPH are warning how some plastic surgeons (PS) are promoting GLP-1s & using them to treat patients & are treating obesity as a cosmetic issue rather than a chronic disease & have made a series of recommendations to PS prescribing GLP-1s https://t.co/AaxmBQbk1L
0
1
3
More outstanding and impactful work by @HamletGasoyan @Ali_Aminian_MD and others from @ClevelandClinic on the health benefits of metabolic surgery. @ASMBS @IfsoSecretariat @WorldObesity @ObesitySociety
New study led by @Ali_Aminian_MD @ClevelandClinic Macrovascular and microvascular outcomes of metabolic surgery vs GLP-1 At the end of the study, patients who underwent surgery had: • 32% lower risk of death • 35% lower risk of major adverse cardiovascular events (MACE), such
0
3
8
🌍 With less than a month before world leaders meet at the UN, obesity risks being side-lined once again. The latest draft Political Declaration is virtually silent on obesity, ignoring over 1 billion people affected today and 4 billion projected by 2035. This is not just a
1
6
15
Promoting healthy habits shouldn’t feel like punishment.💡 Dr. Violeta Moizé reminds us: change starts with understanding, not judgment. Every person is unique. Compassionate, personalized care matters. #bariatricsurgery #ifso #obesitysurgery #metabolicsurgery
0
4
5
Honored to have been asked by @IfsoSecretariat to film this short video about obesity, willpower, and evidence-based treatments. @TempleCPH @TempleUniv @TempleResearch @TempleSBS @WorldObesity @WileyHealth @JournalObesity
"Obesity is not just about willpower" Dr. David Sarwer reminds us it's a complex disease influenced by genetic, metabolic and psychological factors. Effective treatments like surgery and medication are more accessible than ever. No shame in seeking help💪 #bariatricsurgery #IFSO
0
8
12
"Obesity is not just about willpower" Dr. David Sarwer reminds us it's a complex disease influenced by genetic, metabolic and psychological factors. Effective treatments like surgery and medication are more accessible than ever. No shame in seeking help💪 #bariatricsurgery #IFSO
0
12
14
Thrilled to have our recent study on traumatic brain injuries in college athletes featured in @ConversationUS. @TempleUniv @TempleResearch @TempleCPH @TempleATP @TempleSBS
Youth athletes face mental health risks from repeated brain injuries. After the recent NFL HQ shooting linked to #CTE, this new @ConversationUS article by @davidbsarwer @TempleCPH explores long-term impacts of traumatic brain injury in young athletes.
1
2
5
Outstanding visual representation of likely changes in weight with medications and MBS. Can be a great tool for patients. Outstanding, impactful work @rvcohen @PaulinaSalminen and others! @IfsoSecretariat @TheLancetEndo @ASMBS @WorldObesity
Starting #obesity treatment with drugs seems like a good idea. Considering surgery as soon as it stops working is even better. @rvcohen @IfsoSecretariat @PaulinaSalminen @IFSOLAC @ifso_ec @TheLancetEndo
https://t.co/EaRlaPTUPI
0
1
2
IFSO statement@Lancet DE: Med-induced WL isn't a reason to delay bariatric surgery. Many stop meds due to cost, intolerance, or wanting a "definitive" fix. Clinicians must not wait for the predictable relapse of complications. The goal is sustained health, not temporary metrics
2
17
32
Bariatric surgery isn’t standalone, it’s one step in a structured plan. At IFSO, we advocate a holistic approach: nutrition, psychology, activity, support. Better outcomes. Stronger patients. Smarter care. #BariatricSurgery
0
5
13
It's becoming apparent that #GLP1s are having a “contagion effect” in some families. But this effect is a good one with healthier lives for other family members. HT: @jackiesnow @ObesityAction
https://t.co/b0xVlWGbWt
0
7
14
Thrilled to have my session at #ifso2025 highlighted here. Be sure to join us in Santiago in September! @IfsoSecretariat @WorldObesity
0
2
9
Important paper on the role of behavioral health in treating pediatric obesity.
GLP-1 Receptor Agonists for Treatment of Pediatric Obesity: Behavioral Health Considerations, published in @ChildObesity_jn Link to pub: https://t.co/dP9nQLsBR7
2
3
7
Enhance your knowledge of #obesity with @WorldObesity's scientific journals featuring the latest cutting-edge research in the field of #obesity. #SCOPEKnowledge 🩺 Clinical Obesity 🧒 Pediatric Obesity 📑 Obesity Reviews ⚗️ Obesity Science & Practice ➡️ https://t.co/625UkpOW2h
0
4
5
Age, race and ethnicity, and sex of participants in clinical trials related to obesity
onlinelibrary.wiley.com
Objective Federal policies mandate the inclusion of historically marginalized groups in clinical trials and sociodemographic reporting on ClinicalTrials.gov. This study used ClinicalTrials.gov to...
0
1
8